Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

According to Dr Ngugi, digestive problems are one of the most commonly reported side effects of Ozempic. These include nausea ...